Hasnyálmirigyrák: vizsgálatok itt: Németország
53 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in NémetországPhase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
- Where
- Berlin, Bochum, Dresden, Frankfurt am Main, Hamburg, Heidelberg, Heilbronn, Munich, Ulm
- Életkor
- 18 év and over
- People
- 281 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524928-21-00 - 3. fázisTaking peopleA Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
- Where
- Berlin, Bochum, Bonn, Cologne, Dresden, Duesseldorf, Essen, Frankfurt am Main, Freiburg im Breisgau, Goettingen, Halle Saale, Hamburg, Leipzig, Munich, Nuremberg, Ulm
- Életkor
- 18 év and over
- People
- 239 worldwide
- Run by
- Incyte Corp.
See details and how to join2025-525009-18-00 - 1/2. fázisTaking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Cologne, Esslingen am Neckar, Moers, Nuremberg
- Életkor
- 18 év and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - 1. fázisTaking peopleA phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
- Where
- Essen
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521702-18-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Hamburg, Heilbronn, Munich
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 1/2. fázisTaking peopleMaster protocol of TCR-modified T cell therapy targeting HLA-restricted KRAS antigen administered in adult patients with metastatic or locally advanced PDAC
- Where
- Berlin, Dresden, Heidelberg, Leipzig, Munich, Tuebingen
- Életkor
- 18 év and over
- People
- 57 worldwide
- Run by
- Anocca AB
See details and how to join2024-513900-32-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Dresden, Essen, Frankfurt, Ulm, Würzburg
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - No phaseTaking peopleToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
- Where
- Münster, Ulm
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06801899 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Essen
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Cologne, Essen, München, Rostock
- Életkor
- 18 év to 100 év
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192 - No phaseNot yet taking people in NémetországModulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients
- Where
- Cologne
- Életkor
- 18 év and over
- People
- 88
- Run by
- University of Cologne
See details and how to joinNCT06414122 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 2. fázisTaking peopleA Phase II trial of ginisortamab in participants with metastatic pancreatic ductal adenocarcinoma
- Where
- Munich, Ulm
- Életkor
- 18 év and over
- People
- 43 worldwide
- Run by
- Cancer Research UK
See details and how to join2024-514129-43-00 - 2/3. fázisTaking peopleSIL204-SL Treatment for Locally Advanced Pancreatic Cancer
- Where
- Erlangen, Munich, Ulm
- Életkor
- 18 év and over
- People
- 10
- Run by
- Silexion Therapeutics Ltd.
See details and how to join2025-525157-39-00 - 3. fázisNot yet taking people in NémetországShort or long NAT for BR/LAPC (ADVANTAGE Trial)
- Where
- Frankfurt am Main, Hamburg, Heidelberg
- Életkor
- 18 év and over
- People
- 754 worldwide
- Run by
- Vastra Gotalandsregionen
See details and how to join2022-502117-29-00 - 2/3. fázisNot yet taking people in Németország68Ga-FAPI-46 PET for imaging of gastrointestinal cancers: A prospective interventional single-arm clinical trial (FAPI-PET-GI)
- Where
- Essen, Muenster
- Életkor
- 18 év and over
- People
- 150
- Run by
- Universitaetsklinikum Essen AöR
See details and how to join2023-506030-70-00 - 1. fázisTaking peoplePhase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
- Where
- Cologne, Essen, Munich, Rostock
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2023-510356-23-00 - 3. fázisTaking peopleIntensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled trial - METAPANC
- Where
- Aachen, Berlin, Bochum, Cologne, Dresden, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Halle Saale, Hamburg, Hanover, Heidelberg, Lübeck, Mainz, Mannheim, Munich, Münster, Nuremberg, Regensburg, Ulm, Wuerzburg
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Universitaetsmedizin Goettingen
See details and how to join2023-503558-10-00 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - 3. fázisTaking peoplePancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula
- Where
- Dresden
- Életkor
- 18 év and over
- People
- 32
- Run by
- Technische Universität Dresden
See details and how to joinNCT05843877 · EU 2023-507773-17-00 - 4. fázisTaking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Berlin, Tübingen
- Életkor
- 18 év to 64 év
- People
- 2076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - No phaseTaking peopleAssessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler
- Where
- Heidelberg
- Életkor
- 18 év and over
- People
- 110
- Run by
- University Hospital Heidelberg
See details and how to joinNCT06764134 - No phaseTaking peopleComparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
- Where
- Greifswald
- Életkor
- 18 év and over
- People
- 60
- Run by
- University Medicine Greifswald
See details and how to joinNCT05501379 - 2/3. fázisBefejeződöttStudy of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Where
- Berlin, Dresden, Hamburg, Tuebingen, Weiden I D Opf
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Panbela Therapeutics, Inc.
See details and how to joinNCT05254171 · EU 2024-514714-12-00 - No phaseTaking peopleStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Hamburg
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767